Evidence 1
Activity
Activity
Tumor-homing Peptides
Target
Tumor cell
Targeting
Colon carcinoma
CD13, Integrins
Source & Reference
TumorHoPe2.0
TumorHoPe2
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
2020
Tripodi A et al. Pathol Oncol Res. 2019 Dec 9
26(3):1879–1892.
Other
| Source Activity Label | Source Definition |
|---|---|
| Tumor-homing Peptides |
TumorHoPe2.0
experimentally validated tumor-homing peptide annotation.
|
KS, HT-29, MRC-6
Orthotopic HT-29 human colon carcinoma bearing SCID mice, Subcutaneous Kaposi’s sarcoma bearing SCID mice, male BALB/c mice
Synthetic
Daunorubicin (Dau), Aminooxyacetylated (Aoa) Cathepsin B cleavable GFLG
Cyclic